Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Multimodal actions of neural stem cells in a mouse model of ALS: a meta-analysis.

Teng YD, Benn SC, Kalkanis SN, Shefner JM, Onario RC, Cheng B, Lachyankar MB, Marconi M, Li J, Yu D, Han I, Maragakis NJ, Lládo J, Erkmen K, Redmond DE Jr, Sidman RL, Przedborski S, Rothstein JD, Brown RH Jr, Snyder EY.

Sci Transl Med. 2012 Dec 19;4(165):165ra164. doi: 10.1126/scitranslmed.3004579.

PMID:
23253611
2.

Novel functional interactions between Trk kinase and p75 neurotrophin receptor in neuroblastoma cells.

Lachyankar MB, Condon PJ, Daou MC, De AK, Levine JB, Obermeier A, Ross AH.

J Neurosci Res. 2003 Jan 15;71(2):157-72.

PMID:
12503079
3.

Global gene and cell replacement strategies via stem cells.

Park KI, Ourednik J, Ourednik V, Taylor RM, Aboody KS, Auguste KI, Lachyankar MB, Redmond DE, Snyder EY.

Gene Ther. 2002 May;9(10):613-24. Review.

4.

Association of increased phosphatidylinositol 3-kinase signaling with increased invasiveness and gelatinase activity in malignant gliomas.

Kubiatowski T, Jang T, Lachyankar MB, Salmonsen R, Nabi RR, Quesenberry PJ, Litofsky NS, Ross AH, Recht LD.

J Neurosurg. 2001 Sep;95(3):480-8.

PMID:
11565871
5.

PTEN: a newly identified regulator of neuronal differentiation.

Ross AH, Lachyankar MB, Recht LD.

Neuroscientist. 2001 Aug;7(4):278-81. Review.

PMID:
11488393
6.

A role for nuclear PTEN in neuronal differentiation.

Lachyankar MB, Sultana N, Schonhoff CM, Mitra P, Poluha W, Lambert S, Quesenberry PJ, Litofsky NS, Recht LD, Nabi R, Miller SJ, Ohta S, Neel BG, Ross AH.

J Neurosci. 2000 Feb 15;20(4):1404-13.

7.

A novel, nerve growth factor-activated pathway involving nitric oxide, p53, and p21WAF1 regulates neuronal differentiation of PC12 cells.

Poluha W, Schonhoff CM, Harrington KS, Lachyankar MB, Crosbie NE, Bulseco DA, Ross AH.

J Biol Chem. 1997 Sep 19;272(38):24002-7.

8.

Embryonic precursor cells that express Trk receptors: induction of different cell fates by NGF, BDNF, NT-3, and CNTF.

Lachyankar MB, Condon PJ, Quesenberry PJ, Litofsky NS, Recht LD, Ross AH.

Exp Neurol. 1997 Apr;144(2):350-60.

PMID:
9168835
9.

TrkA expression decreases the in vivo aggressiveness of C6 glioma cells.

Lachyankar MB, Ross AH, Litofsky NS, Condon PJ, Quesenberry PJ, Recht LD.

Cancer Res. 1997 Feb 1;57(3):532-6.

10.

The neurotrophin receptor, gp75, forms a complex with the receptor tyrosine kinase TrkA.

Ross AH, Daou MC, McKinnon CA, Condon PJ, Lachyankar MB, Stephens RM, Kaplan DR, Wolf DE.

J Cell Biol. 1996 Mar;132(5):945-53.

11.

A teratocarcinoma-derived neurotrophic activity.

Lachyankar MB, Raval SD, Kayal JJ, Seshadri R, Lalitha VS.

Neuroreport. 1995 May 30;6(8):1195-8.

PMID:
7662906
12.

Retrograde axonal transport and lesion-induced upregulation of the TrkA high-affinity NGF receptor.

Loy R, Lachyankar MB, Condon PJ, Poluha DK, Ross AH.

Exp Neurol. 1994 Dec;130(2):377-86.

PMID:
7532592
13.

Axonal transport of the trkA high-affinity NGF receptor.

Ross AH, Lachyankar MB, Poluha DK, Loy R.

Prog Brain Res. 1994;103:15-21. Review. No abstract available.

PMID:
7533911

Supplemental Content

Loading ...
Support Center